Recent News

• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 08.07.2025 - NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
• 08.07.2025 - NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
• 08.07.2025 - NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
• 07.24.2025 - Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta
• 07.24.2025 - Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta

Recent Filings

• 08.25.2025 - 8-K Current report
• 08.19.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.19.2025 - 3 Initial statement of beneficial ownership of securities
• 08.07.2025 - 8-K Current report
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.29.2025 - EFFECT Notice of Effectiveness
• 07.29.2025 - 424B2 Prospectus [Rule 424(b)(2)]
• 07.28.2025 - CORRESP Correspondence